CDC to Grant Exclusive License for Fungal Infection Detection Technology to Myconostica

Summary

The Centers for Disease Control and Prevention (CDC) is considering granting a worldwide, limited field of use, co-exclusive license to Myconostica, Inc. to practice inventions related to detecting Aspergillus species and other filamentous fungi, as outlined in a patent and patent application.